Mathilde Wagner

3.2k total citations
92 papers, 2.2k citations indexed

About

Mathilde Wagner is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathilde Wagner has authored 92 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hepatology, 33 papers in Epidemiology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathilde Wagner's work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Liver Disease Diagnosis and Treatment (26 papers) and MRI in cancer diagnosis (18 papers). Mathilde Wagner is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Liver Disease Diagnosis and Treatment (26 papers) and MRI in cancer diagnosis (18 papers). Mathilde Wagner collaborates with scholars based in France, United States and Switzerland. Mathilde Wagner's co-authors include Bachir Taouli, Cecilia Besa, Valérie Vilgrain, Octavia Bane, Paul Kennedy, Bernard E. Van Beers, Sabrina Doblas, Ralph Sinkus, Stefanie J. Hectors and Jean‐Luc Daire and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Mathilde Wagner

82 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathilde Wagner France 28 906 866 858 474 427 92 2.2k
Masashi Yamashiro Japan 27 402 0.4× 478 0.6× 1.2k 1.4× 256 0.5× 686 1.6× 121 2.2k
Susanne Kriener Germany 20 815 0.9× 368 0.4× 508 0.6× 186 0.4× 367 0.9× 48 1.7k
Carlo Paties Italy 20 539 0.6× 224 0.3× 660 0.8× 637 1.3× 360 0.8× 51 2.0k
Carlos Nicolau Spain 34 693 0.8× 579 0.7× 880 1.0× 147 0.3× 849 2.0× 114 3.0k
Haruyuki Takaki Japan 32 469 0.5× 386 0.4× 1.1k 1.3× 593 1.3× 1.0k 2.4× 139 3.1k
Hyung Sik Yoo South Korea 25 406 0.4× 444 0.5× 370 0.4× 469 1.0× 1.5k 3.5× 67 2.4k
Kyoung Doo Song South Korea 24 902 1.0× 659 0.8× 1.4k 1.6× 384 0.8× 621 1.5× 117 2.3k
Atsuhiro Nakatsuka Japan 34 616 0.7× 350 0.4× 1.6k 1.9× 575 1.2× 1.3k 3.1× 110 3.4k
Adriano Zangrandi Italy 14 344 0.4× 143 0.2× 510 0.6× 313 0.7× 261 0.6× 29 1.2k
Stephan Clasen Germany 27 241 0.3× 749 0.9× 651 0.8× 271 0.6× 366 0.9× 82 1.8k

Countries citing papers authored by Mathilde Wagner

Since Specialization
Citations

This map shows the geographic impact of Mathilde Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Wagner more than expected).

Fields of papers citing papers by Mathilde Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Wagner. The network helps show where Mathilde Wagner may publish in the future.

Co-authorship network of co-authors of Mathilde Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Wagner. A scholar is included among the top collaborators of Mathilde Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Wagner. Mathilde Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Mathilde, et al.. (2026). Spectral CT imaging in colorectal cancer: current applications, limitations, and future perspectives. Insights into Imaging. 17(1). 39–39.
2.
3.
Colin, Thierry, J.N. Foulquier, S. Guillerm, et al.. (2024). 554: Clinical, dosimetric and radiomics features predictive of lung toxicity after (chemo)radiotherapy. Radiotherapy and Oncology. 194. S4976–S4978. 1 indexed citations
4.
Pesquet, Jean‐Christophe, et al.. (2024). Deep learning for automatic bowel-obstruction identification on abdominal CT. European Radiology. 34(9). 5842–5853. 4 indexed citations
5.
Cannella, Roberto, Marco Dioguardi Burgio, Riccardo Sartoris, et al.. (2024). Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma. Radiology. 310(2). e231160–e231160. 13 indexed citations
6.
Wagner, Mathilde, et al.. (2024). Appendiceal adenocarcinoma, diagnosed after acute perforated appendicitis: Potential contribution of HIPEC. European Journal of Surgical Oncology. 50(3). 107959–107959. 1 indexed citations
7.
Roux, Charles, M. Soret, Mathilde Wagner, et al.. (2024). Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival. Clinics and Research in Hepatology and Gastroenterology. 48(2). 102282–102282. 7 indexed citations
8.
9.
Wagner, Mathilde, Claire Goumard, Olivier Scatton, et al.. (2023). Portal‐hypertension features are associated with ascites occurrence and survival in patients with hepatocellular carcinoma treated by external radiotherapy. United European Gastroenterology Journal. 11(10). 985–997. 3 indexed citations
10.
Bardier, A, et al.. (2023). Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN). SHILAP Revista de lepidopterología. 9(1). 31–37. 1 indexed citations
11.
Campani, Claudia, Manon Allaire, Philippe Sultanik, et al.. (2023). Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab. Hepatology. 79(1). 49–60. 14 indexed citations
12.
Couty, Jean‐Pierre, Philippe Sultanik, Claudia Campani, et al.. (2023). Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102199–102199. 1 indexed citations
13.
Campani, Claudia, Lorraine Blaise, Nathalie Ganne‐Carrié, et al.. (2022). Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab. Liver International. 43(3). 708–717. 27 indexed citations
14.
Sultanik, Philippe, Lorraine Blaise, Mathilde Wagner, et al.. (2022). A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC. Liver International. 42(12). 2843–2854. 19 indexed citations
15.
16.
Boeken, Tom, et al.. (2020). Association of shear-wave elastography with clinical outcomes post-liver transplantation. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101554–101554. 7 indexed citations
17.
Wagner, Mathilde, Sabrina Doblas, Nicolas Poté, et al.. (2019). Comparison of pulsed and oscillating gradient diffusion‐weighted MRI for characterizing hepatocellular nodules in liver cirrhosis: ex vivo study in a rat model. Journal of Magnetic Resonance Imaging. 51(4). 1065–1074. 3 indexed citations
18.
Lamuraglia, Michele, Stéphane Oudard, Bernard Escudier, et al.. (2015). mTOR-inhibitor treatment of metastatic renal cell carcinoma: contribution of Choi and modified Choi criteria assessed in 2D or 3D to evaluate tumor response. European Radiology. 26(1). 278–285. 13 indexed citations
19.
Wagner, Mathilde, Léon Maggiori, Maxime Ronot, et al.. (2013). Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference. European Radiology. 23(8). 2156–2164. 8 indexed citations
20.
Deery, Chris, et al.. (2001). The prevalence of dental erosion in a United States and a United Kingdom sample of adolescents.. PubMed. 22(6). 505–10. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masashi Yamashiro Breakdown of academic impact, for papers by Susanne Kriener Breakdown of academic impact, for papers by Carlo Paties Breakdown of academic impact, for papers by Carlos Nicolau Breakdown of academic impact, for papers by Haruyuki Takaki Breakdown of academic impact, for papers by Hyung Sik Yoo Breakdown of academic impact, for papers by Kyoung Doo Song Breakdown of academic impact, for papers by Atsuhiro Nakatsuka Breakdown of academic impact, for papers by Adriano Zangrandi Breakdown of academic impact, for papers by Stephan Clasen
Rankless by CCL
2026